Fiore Giovina, Florio Pasquale, Micheli Lucia, Nencini Cristina, Rossi Marco, Cerretani Daniela, Ambrosini Guido, Giorgi Giorgio, Petraglia Felice
Department of Obstetrics and Gynecology, Giorgio Segre, University of Siena, Siena, Italy.
J Clin Endocrinol Metab. 2005 Jul;90(7):4205-10. doi: 10.1210/jc.2004-1632. Epub 2005 Apr 19.
Preeclampsia (PE) is a disorder that occurs only during pregnancy. The placenta has a controlling role in this condition. Recent literature suggests that the oxidative stress is a component of PE and plays a main role in the link between decreased placental perfusion and the impaired function of maternal endothelium.
Because the human placenta expresses endothelin-1 (ET-1) and its circulating levels are high in pregnancies complicated with PE, the present study investigated the role of ET-1 on placental oxidative stress pathways.
Human placental explants, JEG-3, and primary cytotrophoblast cells were cultured with increasing ET-1 concentrations for 6 and 24 h.
The study was conducted at tertiary clinical care centers in Siena and Padova, Italy.
Human placental explants, JEG-3, and primary cytotrophoblast cells were used to test ET-1 effect.
MAIN OUTCOME MEASURE(S): The main outcome measure was ET-1 mRNA and its receptor mRNAs, type A and B, detection by RT-PCR. The common markers of oxidative stress [malondialdehyde (MDA), glutathione (GSH), glutathione disulfide (GSSG), ascorbic acid (AA)] as well as cell proliferation and vitality were measured after stimulation periods.
ET-1 inhibits cell proliferation and vitality and triggers oxidative stress in the human placenta by altering the balance between oxidant (increased MDA levels) and antioxidant (decreased GSH, GSSG, and AA) forces in favor of oxidation.
Because MDA damages endothelial cells, whereas GSH, GSSG, and AA protect them, we postulate that ET-1 may be one of the key links between primary placental disorders and the systemic endothelial dysfunction of PE.
